Conclusions In summary, the results of this large active comparator, new user cohort study indicate that GLP-1 receptor agonists are not associated with an increased risk of suicidal ideation, self-harm, and suicide when compared with DPP-4 inhibitors or SGLT-2 inhibitors among patients with type 2 diabetes
Patients who are already tolerating the oral medication may begin at the 1.7 mg or 2.4 mg injection maintenance dose by consulting with their healthcare provider without restarting the injection titration schedule from 0.25 mg
The study found that semaglutide and tirzepatide, the active ingredients in now-commercial drugs like Ozempic, Wegovy, Mounjaro and Zepbound, were all linked to notable levels of hair loss, and that this hair loss was strongest among those who had been using higher doses of GLP-1s to target rapid weight loss for critical health reasons
Reddy's Laboratories for an injectable generic version of semaglutide, the active ingredient in Ozempic and Wegovy [Source: theglobeandmail.com/business/economy/article-generic-ozempic-glp1-approved-health-canada]
.png)
